Skip to content

Long Term Follow up of the Titanium Modular Revision Hip System up (TinT 10) Levels

Long Term Follow up of the Titanium Modular Revision Hip System up (TinT 10)

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06033651
Acronym
TinT10
Enrollment
100
Registered
2023-09-13
Start date
2025-04-10
Completion date
2026-05-14
Last updated
2025-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Surgery

Brief summary

Patients are to be approached to attend clinic who have been identified as being implanted with either a Lima Corporate Delta Revision TT, Delta One TT or the Delta Multihole Systems hip systems between 2011 and 2015, a minimum of 10 years since hip surgery. They will be x-rayed (AP pelvis and a lateral view) and have a clinical review in clinic.

Detailed description

Since its popularisation in the 1960's, Hip replacements have become one of the NHS's highest volume procedures. Unfortunately, hip replacements can fail with on average 8,500 revision hip replacements being performed each year pre-covid(1). Often this is very complex with destruction of the normal anatomy leaving surgeons with a significant challenge in ensuring appropriate positioning of the socket within the confines of the patient's anatomy. The Lima Corporate Delta systems are designed to help surgeons with this very problem by providing the option of a 'face changer' allowing surgeons to place a socket within a socket. To allow for this function, the 'face changer' must connect with the acetabular cup (socket). 140 patients have been identified as having had this modular acetabular system implanted at the RJAH in 2012 & 2014, going into 2015. The aim of this study is to therefore identify the survivorship of these implants at 10 years.

Interventions

RADIATIONx-ray

AP view of pelvis

Sponsors

Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

All adult patients who had Lima Corporate modular titanium acetabular component implants implanted between 2011 and 2015.

Exclusion criteria

Deceased patients Patients who have undergone a subsequent acetabular revision Patients that lack capacity Prisoners in the custody of HM Prison service or who are offenders supervised by the probation service in England or Wales.

Design outcomes

Primary

MeasureTime frameDescription
The survivourship of the modular acetabular hip system at 10 years post-opParticipants will be invited to attend a one time clinic visit, after which their participation in the study has ended.This study will be the largest study to look at the survivorship of this acetabular system. Survivorship will be to the point of revision and clinical outcome survivorship is to the point of radiological loosening and PROMs data collection.

Contacts

Primary ContactJulie Steen
julie.steen@nhs.net+441691404418
Backup ContactThomas Banks
thomas.banks3@nhs.net+441691404418

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026